Study finds how virtual blood vessel technology improves heart disease care

Study finds how virtual blood vessel technology improves heart disease care The research team discovered that integrating the VIRTUHeartTM technology with clinicians treating heart attack patients would have improved the management of more than 20 per cent of patients. https://ift.tt/Xk01f8x

Be Healthy And Handsome

submitted by /u/HEALTHBEFINE
[link] [comments]

Active COVID cases in country dip to 3,001

Active COVID cases in country dip to 3,001 The active cases now comprise 0.01 per cent of the total infections and the national COVID-19 recovery rate has been recorded at 98.81 per cent. https://ift.tt/Xk01f8x

India committed to minimise digital divide: VK Paul at G20’s 3rd HWG Meeting

India committed to minimise digital divide: VK Paul at G20’s 3rd HWG Meeting The member (Health), NITI Aayog VK Paul stated that India's digital infrastructure and capabilities are enablers of global economic growth and human development. Emphasised that by promoting digital solutions and innovation to aid universal health coverage, the digital divide can be bridged. https://ift.tt/Xk01f8x

Novo Nordisk in talks buy controlling stake in Biocorp

Novo Nordisk in talks buy controlling stake in Biocorp The Danish company said it had entered into exclusive negotiations with Bio Jag, Biocorp's main shareholder, for the purchase of its over 45 per cent stake in the French company at a price of 35.0 euros ($37.44) per share in cash. Certain minority shareholders, representing 19.0 per cent of the share capital of Biocorp, will also transfer shares to Novo Nordisk. https://ift.tt/Xk01f8x

With few MDs practicing in rural areas, a different type of doctor is filling the gap

submitted by /u/Maxcactus [link] [comments]

Content posted against Serum Institute of India prima facie defamatory: Bombay HC

Content posted against Serum Institute of India prima facie defamatory: Bombay HC The SII filed a defamation suit in December 2022 seeking damages to the tune of Rs 100 crore from the two individuals and their organisations for allegedly posting erroneous content against the company and its COVID-19 vaccine Covishield. The high court on Monday in its interim order said it was of the prima facie view that the SII has satisfied that the contents and accusations made by the two persons were defamatory. https://ift.tt/Xk01f8x